Glei Dana A, Goldman Noreen
Department of Demography, University of California, Berkeley, CA, USA.
Ann Epidemiol. 2006 Jul;16(7):510-5. doi: 10.1016/j.annepidem.2005.09.010. Epub 2006 Jan 27.
Studies based on Western populations showed a negative relationship between dehydroepiandrosterone sulfate (DHEAS) level and mortality, but no study examined this relationship in a non-Western country. We use data from a large, nationally representative sample (n = 963) of older Taiwanese to investigate whether serum DHEAS, predicts subsequent mortality during a 3-year period (2000 to 2003) and whether an effect remains after controlling for baseline health status.
Baseline data collection included an individual interview, physical examination, and blood sample. A logit model is used to test the relationship between DHEAS level and risk for mortality, controlling for age, sex, and smoking status.
Results show a marginally significant inverse relationship between DHEAS level and 3-year mortality risk. Participants with low DHEAS levels (<54.5 microg/dL) have 64% greater odds of dying than those with higher DHEAS levels (p < 0.06). After adjusting for various indicators of health status in 2000, the odds ratio (OR) for low DHEAS level remains substantial (OR = 1.41), but not statistically significant.
Although the analysis is limited by the short follow-up and small number of deaths, results are consistent with the notion that DHEAS level has a sizeable effect on mortality.
基于西方人群的研究表明硫酸脱氢表雄酮(DHEAS)水平与死亡率之间呈负相关,但尚无研究在非西方国家考察这种关系。我们利用来自台湾老年人群的一个具有全国代表性的大样本(n = 963)数据,来调查血清DHEAS是否能预测3年期间(2000年至2003年)随后的死亡率,以及在控制基线健康状况后这种效应是否依然存在。
基线数据收集包括个人访谈、体格检查和血液样本采集。采用logit模型来检验DHEAS水平与死亡风险之间的关系,并控制年龄、性别和吸烟状况。
结果显示DHEAS水平与3年死亡风险之间存在微弱的显著负相关。DHEAS水平低(<54.5微克/分升)的参与者死亡几率比DHEAS水平高的参与者高64%(p < 0.06)。在对2000年各种健康状况指标进行调整后,低DHEAS水平的优势比(OR)仍然很大(OR = 1.41),但无统计学意义。
尽管该分析受到随访时间短和死亡人数少的限制,但结果与DHEAS水平对死亡率有显著影响这一观点一致。